What is the opinion of the Work Group regarding ACE-Is and ARBs in patients with diabetes and proteinuria?
In the opinion of the Work Group, ACE-Is and ARBs are likely to be similarly effective in improving outcomes in patients with diabetes and proteinuria. Practitioners should therefore base prescribing decisions on the evidence available for each class, the risk of side effects, and cost considerations.